Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Roderburg

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Gut Microbes|July 10, 2014
The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinomaChristoph Roderburg, Tom Luedde
Journal of Hepatology|October 13, 2014
Circulating microRNAs as markers of liver inflammation, fibrosis and cancerChristoph Roderburg, Tom Luedde
Hepatology (Baltimore, Md.)|May 1, 2010
Obesity and liver cancer: a key role for interleukin-6 and signal transducer and activator of transcription 3?Christoph Roderburg, Christian Trautwein
Journal of Hepatology|October 6, 2016
Cell-specific functions of miRNA in the liverChristoph Roderburg, Christian Trautwein
Digestive Diseases and Sciences|July 30, 2021
Prevalence of Hospitalization and Readmission in Patients with Inflammatory Bowel DiseasesKarel Kostev, Sven Loosen, Christoph Roderburg
Hepatology (Baltimore, Md.)|July 28, 2011
MicroRNA-199a/b-3p: a new star in the liver microcosmosChristoph Roderburg, Christian Trautwein, Tom Luedde
Alimentary Pharmacology & Therapeutics|May 7, 2024
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' replyRaphael Mohr, Frank Tacke, Christoph Roderburg
Deutsche Medizinische Wochenschrift (1946)|November 17, 2020
[The Gastrointestinal Tract in Intensive Care Medicine - Overview 2020]Alexander Wree, Christoph Roderburg, Frank Tacke
Digestive Diseases (Basel, Switzerland)|October 31, 2012
TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?Christoph Roderburg, Jeremie Gautheron, Tom Luedde
Visceral Medicine|July 15, 2016
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and PrognosisChristoph Roderburg, Frank Tacke, Christian Trautwein
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Gut Microbes|July 10, 2014
The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinomaChristoph Roderburg, Tom Luedde
Journal of Hepatology|October 13, 2014
Circulating microRNAs as markers of liver inflammation, fibrosis and cancerChristoph Roderburg, Tom Luedde
Hepatology (Baltimore, Md.)|May 1, 2010
Obesity and liver cancer: a key role for interleukin-6 and signal transducer and activator of transcription 3?Christoph Roderburg, Christian Trautwein
Journal of Hepatology|October 6, 2016
Cell-specific functions of miRNA in the liverChristoph Roderburg, Christian Trautwein
Digestive Diseases and Sciences|July 30, 2021
Prevalence of Hospitalization and Readmission in Patients with Inflammatory Bowel DiseasesKarel Kostev, Sven Loosen, Christoph Roderburg
Hepatology (Baltimore, Md.)|July 28, 2011
MicroRNA-199a/b-3p: a new star in the liver microcosmosChristoph Roderburg, Christian Trautwein, Tom Luedde
Alimentary Pharmacology & Therapeutics|May 7, 2024
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' replyRaphael Mohr, Frank Tacke, Christoph Roderburg
Deutsche Medizinische Wochenschrift (1946)|November 17, 2020
[The Gastrointestinal Tract in Intensive Care Medicine - Overview 2020]Alexander Wree, Christoph Roderburg, Frank Tacke
Digestive Diseases (Basel, Switzerland)|October 31, 2012
TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?Christoph Roderburg, Jeremie Gautheron, Tom Luedde
Visceral Medicine|July 15, 2016
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and PrognosisChristoph Roderburg, Frank Tacke, Christian Trautwein
Pageof 30